Literature DB >> 20019654

Imported case of Marburg hemorrhagic fever - Colorado, 2008.

.   

Abstract

Marburg hemorrhagic fever (MHF) is a rare, viral hemorrhagic fever (VHF); the causative agent is an RNA virus in the family Filoviridae, and growing evidence demonstrates that fruit bats are the natural reservoir of Marburg virus (MARV). On January 9, 2008, an infectious disease physician notified the Colorado Department of Public Health and Environment (CDPHE) of a case of unexplained febrile illness requiring hospitalization in a woman who had returned from travel in Uganda. Testing of early convalescent serum demonstrated no evidence of infection with agents that cause tropical febrile illnesses, including VHF. Six months later, in July 2008, the patient requested repeat testing after she learned of the death from MHF of a Dutch tourist who had visited the same bat-roosting cave as the patient, the Python Cave in Queen Elizabeth National Park, Uganda. The convalescent serologic testing revealed evidence of prior infection with MARV, and MARV RNA was detected in the archived early convalescent serum. A public health investigation did not identify illness consistent with secondary MHF transmission among her contacts, and no serologic evidence of infection was detected among the six tested of her eight tour companions. The patient might have acquired MARV infection through exposure to bat secretions or excretions while visiting the Python Cave. Travelers should be aware of the risk for acquiring MHF in caves or mines inhabited by bats in endemic areas in sub-Saharan Africa. Health-care providers should consider VHF among travelers returning from endemic areas who experience unexplained febrile illness.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20019654

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  68 in total

1.  Clinical aspects of Marburg hemorrhagic fever.

Authors:  Masfique Mehedi; Allison Groseth; Heinz Feldmann; Hideki Ebihara
Journal:  Future Virol       Date:  2011-09       Impact factor: 1.831

2.  The global dimensions of public health preparedness and implications for US action.

Authors:  Melinda Moore
Journal:  Am J Public Health       Date:  2012-04-19       Impact factor: 9.308

3.  Mechanism of human antibody-mediated neutralization of Marburg virus.

Authors:  Andrew I Flyak; Philipp A Ilinykh; Charles D Murin; Tania Garron; Xiaoli Shen; Marnie L Fusco; Takao Hashiguchi; Zachary A Bornholdt; James C Slaughter; Gopal Sapparapu; Curtis Klages; Thomas G Ksiazek; Andrew B Ward; Erica Ollmann Saphire; Alexander Bukreyev; James E Crowe
Journal:  Cell       Date:  2015-02-26       Impact factor: 41.582

4.  Detection of all known filovirus species by reverse transcription-polymerase chain reaction using a primer set specific for the viral nucleoprotein gene.

Authors:  Hirohito Ogawa; Hiroko Miyamoto; Hideki Ebihara; Kimihito Ito; Shigeru Morikawa; Heinz Feldmann; Ayato Takada
Journal:  J Virol Methods       Date:  2010-11-17       Impact factor: 2.014

5.  The Tyro3 receptor kinase Axl enhances macropinocytosis of Zaire ebolavirus.

Authors:  Catherine L Hunt; Andrey A Kolokoltsov; Robert A Davey; Wendy Maury
Journal:  J Virol       Date:  2010-11-03       Impact factor: 5.103

6.  The cytoplasmic domain of Marburg virus GP modulates early steps of viral infection.

Authors:  Eva Mittler; Larissa Kolesnikova; Bettina Hartlieb; Robert Davey; Stephan Becker
Journal:  J Virol       Date:  2011-06-15       Impact factor: 5.103

7.  Outbreak of Marburg hemorrhagic fever among miners in Kamwenge and Ibanda Districts, Uganda, 2007.

Authors:  Jennifer Adjemian; Eileen C Farnon; Florimond Tschioko; Joseph F Wamala; Emmanuel Byaruhanga; Godfrey S Bwire; Edgar Kansiime; Atek Kagirita; Sam Ahimbisibwe; F Katunguka; Ben Jeffs; Julius J Lutwama; Robert Downing; Jordan W Tappero; Pierre Formenty; Brian Amman; Craig Manning; Jonathan Towner; Stuart T Nichol; Pierre E Rollin
Journal:  J Infect Dis       Date:  2011-11       Impact factor: 5.226

8.  Marburg virus infection in nonhuman primates: Therapeutic treatment by lipid-encapsulated siRNA.

Authors:  Emily P Thi; Chad E Mire; Raul Ursic-Bedoya; Joan B Geisbert; Amy C H Lee; Krystle N Agans; Marjorie Robbins; Daniel J Deer; Karla A Fenton; Ian MacLachlan; Thomas W Geisbert
Journal:  Sci Transl Med       Date:  2014-08-20       Impact factor: 17.956

9.  Filovirus emergence and vaccine development: a perspective for health care practitioners in travel medicine.

Authors:  Uzma N Sarwar; Sandra Sitar; Julie E Ledgerwood
Journal:  Travel Med Infect Dis       Date:  2010-06-26       Impact factor: 6.211

10.  Rapid detection of filoviruses by real-time TaqMan polymerase chain reaction assays.

Authors:  Yi Huang; Hongping Wei; Yunpeng Wang; Zhengli Shi; Herve Raoul; Zhiming Yuan
Journal:  Virol Sin       Date:  2012-09-21       Impact factor: 4.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.